Abstract
Journal of Ocular Pharmacology and TherapeuticsVol. 39, No. 2 Featured ColumnEyes on New Product DevelopmentGary D. NovackGary D. NovackAddress correspondence to: Dr. Gary D. Novack, PharmaLogic Development, Inc., 17 Bridgegate Drive, San Rafael, CA 94903, USA E-mail Address: gary_novack@pharmalogic.comPharmaLogic Development, Inc., San Rafael, California, USA.Department of Ophthalmology, University of California, Davis, School of Medicine, Sacramento, California, USA.Search for more papers by this authorPublished Online:16 Mar 2023https://doi.org/10.1089/jop.2023.29101.gdnAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Eyes on New Product Development." Journal of Ocular Pharmacology and Therapeutics, 39(2), pp. 87–88FiguresReferencesRelatedDetails Volume 39Issue 2Mar 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Gary D. Novack.Eyes on New Product Development.Journal of Ocular Pharmacology and Therapeutics.Mar 2023.87-88.http://doi.org/10.1089/jop.2023.29101.gdnPublished in Volume: 39 Issue 2: March 16, 2023Online Ahead of Print:February 8, 2023PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
